Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
Identifieur interne : 001F63 ( Main/Exploration ); précédent : 001F62; suivant : 001F64Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
Auteurs : Joep Van Der Leeuw [Pays-Bas] ; Frank L J. Visseren [Pays-Bas] ; Mark Woodward [Australie] ; Yolanda Van Der Graaf [Pays-Bas] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; Neil Poulter [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Source :
- Diabetologia [ 1432-0428 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antihypertenseurs (effets indésirables), Antihypertenseurs (usage thérapeutique), Association médicamenteuse, Comportement de réduction des risques, Diabète de type 2 (traitement médicamenteux), Facteurs de risque, Femelle, Gliclazide (effets indésirables), Gliclazide (usage thérapeutique), Humains, Hypoglycémiants (effets indésirables), Hypoglycémiants (usage thérapeutique), Hypoglycémie (traitement médicamenteux), Hémoglobine A glycosylée (métabolisme), Indapamide (effets indésirables), Indapamide (usage thérapeutique), Maladies cardiovasculaires (), Mâle, Médecine individualisée (), Périndopril (effets indésirables), Périndopril (usage thérapeutique), Sujet âgé.
- MESH :
- effets indésirables : Antihypertenseurs, Gliclazide, Hypoglycémiants, Indapamide, Périndopril.
- métabolisme : Hémoglobine A glycosylée.
- traitement médicamenteux : Diabète de type 2, Hypoglycémie.
- usage thérapeutique : Antihypertenseurs, Gliclazide, Hypoglycémiants, Indapamide, Périndopril.
- Adulte d'âge moyen, Association médicamenteuse, Comportement de réduction des risques, Facteurs de risque, Femelle, Humains, Maladies cardiovasculaires, Mâle, Médecine individualisée, Sujet âgé.
English descriptors
- KwdEn :
- Aged, Antihypertensive Agents (adverse effects), Antihypertensive Agents (therapeutic use), Cardiovascular Diseases (prevention & control), Diabetes Mellitus, Type 2 (drug therapy), Drug Combinations, Female, Gliclazide (adverse effects), Gliclazide (therapeutic use), Hemoglobin A, Glycosylated (metabolism), Humans, Hypoglycemia (drug therapy), Hypoglycemic Agents (adverse effects), Hypoglycemic Agents (therapeutic use), Indapamide (adverse effects), Indapamide (therapeutic use), Male, Middle Aged, Perindopril (adverse effects), Perindopril (therapeutic use), Precision Medicine (methods), Risk Factors, Risk Reduction Behavior.
- MESH :
- chemical , adverse effects : Antihypertensive Agents, Gliclazide, Hypoglycemic Agents, Indapamide, Perindopril.
- chemical , metabolism : Hemoglobin A, Glycosylated.
- chemical , therapeutic use : Antihypertensive Agents, Gliclazide, Hypoglycemic Agents, Indapamide, Perindopril.
- drug therapy : Diabetes Mellitus, Type 2, Hypoglycemia.
- methods : Precision Medicine.
- prevention & control : Cardiovascular Diseases.
- Aged, Drug Combinations, Female, Humans, Male, Middle Aged, Risk Factors, Risk Reduction Behavior.
Abstract
Intensive glucose control reduces the risk of vascular complications while increasing the risk of severe hypoglycaemia at a group level. We sought to estimate individual beneficial and adverse effects of intensive glucose control in patients with type 2 diabetes.
DOI: 10.1007/s00125-016-4082-5
PubMed: 27586250
Affiliations:
- Australie, France, Italie, Pays-Bas, Royaume-Uni
- Angleterre, Grand Londres, Lombardie, Nouvelle-Galles du Sud, Utrecht (province), Victoria (État), Île-de-France
- Londres, Melbourne, Milan, Paris, Sydney, Utrecht
- Université de Melbourne, Université de Sydney
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001455
- to stream PubMed, to step Curation: 001433
- to stream PubMed, to step Checkpoint: 001433
- to stream Ncbi, to step Merge: 003A81
- to stream Ncbi, to step Curation: 003A81
- to stream Ncbi, to step Checkpoint: 003A81
- to stream Main, to step Merge: 001F62
- to stream Main, to step Curation: 001F63
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.</title><author><name sortKey="Van Der Leeuw, Joep" sort="Van Der Leeuw, Joep" uniqKey="Van Der Leeuw J" first="Joep" last="Van Der Leeuw">Joep Van Der Leeuw</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Visseren, Frank L J" sort="Visseren, Frank L J" uniqKey="Visseren F" first="Frank L J" last="Visseren">Frank L J. Visseren</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands. f.l.j.visseren@umcutrecht.nl.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Van Der Graaf, Yolanda" sort="Van Der Graaf, Yolanda" uniqKey="Van Der Graaf Y" first="Yolanda" last="Van Der Graaf">Yolanda Van Der Graaf</name><affiliation wicri:level="3"><nlm:affiliation>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Grobbee, Diederick E" sort="Grobbee, Diederick E" uniqKey="Grobbee D" first="Diederick E" last="Grobbee">Diederick E. Grobbee</name><affiliation wicri:level="3"><nlm:affiliation>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="4"><nlm:affiliation>The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Heller, Simon" sort="Heller, Simon" uniqKey="Heller S" first="Simon" last="Heller">Simon Heller</name><affiliation wicri:level="1"><nlm:affiliation>University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>Istituto Auxologico Italiano, University of Milano-Bicocca, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto Auxologico Italiano, University of Milano-Bicocca, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>International Centre for Circulatory Health, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>International Centre for Circulatory Health, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27586250</idno><idno type="pmid">27586250</idno><idno type="doi">10.1007/s00125-016-4082-5</idno><idno type="wicri:Area/PubMed/Corpus">001455</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001455</idno><idno type="wicri:Area/PubMed/Curation">001433</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001433</idno><idno type="wicri:Area/PubMed/Checkpoint">001433</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001433</idno><idno type="wicri:Area/Ncbi/Merge">003A81</idno><idno type="wicri:Area/Ncbi/Curation">003A81</idno><idno type="wicri:Area/Ncbi/Checkpoint">003A81</idno><idno type="wicri:Area/Main/Merge">001F62</idno><idno type="wicri:Area/Main/Curation">001F63</idno><idno type="wicri:Area/Main/Exploration">001F63</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.</title><author><name sortKey="Van Der Leeuw, Joep" sort="Van Der Leeuw, Joep" uniqKey="Van Der Leeuw J" first="Joep" last="Van Der Leeuw">Joep Van Der Leeuw</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Visseren, Frank L J" sort="Visseren, Frank L J" uniqKey="Visseren F" first="Frank L J" last="Visseren">Frank L J. Visseren</name><affiliation wicri:level="3"><nlm:affiliation>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands. f.l.j.visseren@umcutrecht.nl.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Vascular Medicine, University Medical Centre Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Van Der Graaf, Yolanda" sort="Van Der Graaf, Yolanda" uniqKey="Van Der Graaf Y" first="Yolanda" last="Van Der Graaf">Yolanda Van Der Graaf</name><affiliation wicri:level="3"><nlm:affiliation>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Grobbee, Diederick E" sort="Grobbee, Diederick E" uniqKey="Grobbee D" first="Diederick E" last="Grobbee">Diederick E. Grobbee</name><affiliation wicri:level="3"><nlm:affiliation>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="4"><nlm:affiliation>The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Heller, Simon" sort="Heller, Simon" uniqKey="Heller S" first="Simon" last="Heller">Simon Heller</name><affiliation wicri:level="1"><nlm:affiliation>University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>Istituto Auxologico Italiano, University of Milano-Bicocca, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto Auxologico Italiano, University of Milano-Bicocca, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>International Centre for Circulatory Health, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>International Centre for Circulatory Health, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></analytic><series><title level="j">Diabetologia</title><idno type="eISSN">1432-0428</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antihypertensive Agents (adverse effects)</term><term>Antihypertensive Agents (therapeutic use)</term><term>Cardiovascular Diseases (prevention & control)</term><term>Diabetes Mellitus, Type 2 (drug therapy)</term><term>Drug Combinations</term><term>Female</term><term>Gliclazide (adverse effects)</term><term>Gliclazide (therapeutic use)</term><term>Hemoglobin A, Glycosylated (metabolism)</term><term>Humans</term><term>Hypoglycemia (drug therapy)</term><term>Hypoglycemic Agents (adverse effects)</term><term>Hypoglycemic Agents (therapeutic use)</term><term>Indapamide (adverse effects)</term><term>Indapamide (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Perindopril (adverse effects)</term><term>Perindopril (therapeutic use)</term><term>Precision Medicine (methods)</term><term>Risk Factors</term><term>Risk Reduction Behavior</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antihypertenseurs (effets indésirables)</term><term>Antihypertenseurs (usage thérapeutique)</term><term>Association médicamenteuse</term><term>Comportement de réduction des risques</term><term>Diabète de type 2 (traitement médicamenteux)</term><term>Facteurs de risque</term><term>Femelle</term><term>Gliclazide (effets indésirables)</term><term>Gliclazide (usage thérapeutique)</term><term>Humains</term><term>Hypoglycémiants (effets indésirables)</term><term>Hypoglycémiants (usage thérapeutique)</term><term>Hypoglycémie (traitement médicamenteux)</term><term>Hémoglobine A glycosylée (métabolisme)</term><term>Indapamide (effets indésirables)</term><term>Indapamide (usage thérapeutique)</term><term>Maladies cardiovasculaires ()</term><term>Mâle</term><term>Médecine individualisée ()</term><term>Périndopril (effets indésirables)</term><term>Périndopril (usage thérapeutique)</term><term>Sujet âgé</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antihypertensive Agents</term><term>Gliclazide</term><term>Hypoglycemic Agents</term><term>Indapamide</term><term>Perindopril</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemoglobin A, Glycosylated</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antihypertensive Agents</term><term>Gliclazide</term><term>Hypoglycemic Agents</term><term>Indapamide</term><term>Perindopril</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Hypoglycemia</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antihypertenseurs</term><term>Gliclazide</term><term>Hypoglycémiants</term><term>Indapamide</term><term>Périndopril</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Precision Medicine</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hémoglobine A glycosylée</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cardiovascular Diseases</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Diabète de type 2</term><term>Hypoglycémie</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihypertenseurs</term><term>Gliclazide</term><term>Hypoglycémiants</term><term>Indapamide</term><term>Périndopril</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Drug Combinations</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Risk Reduction Behavior</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association médicamenteuse</term><term>Comportement de réduction des risques</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Maladies cardiovasculaires</term><term>Mâle</term><term>Médecine individualisée</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Intensive glucose control reduces the risk of vascular complications while increasing the risk of severe hypoglycaemia at a group level. We sought to estimate individual beneficial and adverse effects of intensive glucose control in patients with type 2 diabetes.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Italie</li><li>Pays-Bas</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Lombardie</li><li>Nouvelle-Galles du Sud</li><li>Utrecht (province)</li><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Londres</li><li>Melbourne</li><li>Milan</li><li>Paris</li><li>Sydney</li><li>Utrecht</li></settlement><orgName><li>Université de Melbourne</li><li>Université de Sydney</li></orgName></list><tree><country name="Pays-Bas"><region name="Utrecht (province)"><name sortKey="Van Der Leeuw, Joep" sort="Van Der Leeuw, Joep" uniqKey="Van Der Leeuw J" first="Joep" last="Van Der Leeuw">Joep Van Der Leeuw</name></region><name sortKey="Grobbee, Diederick E" sort="Grobbee, Diederick E" uniqKey="Grobbee D" first="Diederick E" last="Grobbee">Diederick E. Grobbee</name><name sortKey="Van Der Graaf, Yolanda" sort="Van Der Graaf, Yolanda" uniqKey="Van Der Graaf Y" first="Yolanda" last="Van Der Graaf">Yolanda Van Der Graaf</name><name sortKey="Visseren, Frank L J" sort="Visseren, Frank L J" uniqKey="Visseren F" first="Frank L J" last="Visseren">Frank L J. Visseren</name></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name></region><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Heller, Simon" sort="Heller, Simon" uniqKey="Heller S" first="Simon" last="Heller">Simon Heller</name></noRegion><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name></country><country name="Italie"><region name="Lombardie"><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name></region></country><country name="France"><region name="Île-de-France"><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F63 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F63 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27586250
|texte= Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27586250" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |